Поисковый запрос: (<.>S=VAD<.>) |
Общее количество найденных документов : 81
Показаны документы с 1 по 20
|
|
1.
| HIA-VAD improvements based on animal experiments // Int. J. Artif. Organs, 1993. Vol. 16, N 6.-С.397
|
2.
| IgE Plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-'альфа' // Amer. J. Hematol., 1994. Vol. 45, N 3.-С.262-264
|
3.
| Gisselbrecht C. Le traitement du myelome // Concours med., 1996. Vol. 118, N 4.-С.201-204
|
4.
| Patients with multiple myeloma requiring long-term dialysis: Presenting features, response to therapy, and outcome in a series of 20 cases // Brit. J. Haematol., 1995. Vol. 91, N 4.-С.854-859
|
5.
| Loddick Sarah A. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat // NeuroReport, 1996. Vol. 7, N 9.-С.1465-1468
|
6.
| Loddick Sarah A. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat // NeuroReport, 1996. Vol. 7, N 9.-С.1465-1468
|
7.
| A randomized study of VAD therapy with either concurrent or maintenance interferon in patients with newly diagnosed multiple myeloma // Brit. J. Haematol., 1996. Vol. 94, N 4.-С.659-664
|
8.
| Treatment of refractory multiple myeloma // Scr. med., 1995. Vol. 68, N 1-2.-С.3-13
|
9.
| Treatment of refractory multiple myeloma // Scr. med., 1995. Vol. 68, N 1-2.-С.3-13
|
10.
| Tiplady C.W. Continuous low dose oral dexamethasone as salvage therapy in resistant myeloma // Brit. J. Haematol., 1997. Vol. 97, Suppl. n 1.-С.23
|
11.
| giles Fancis J. Refractory multiple myeloma: Recent advances in therapy // Hematol. Pathol., 1995. Vol. 9, N 3-4.-С.121-140
|
12.
| giles Fancis J. Refractory multiple myeloma: Recent advances in therapy // Hematol. Pathol., 1995. Vol. 9, N 3-4.-С.121-140
|
13.
| Myeloid markers in adult acute lymphocytic leukemia: Correlations with patient and disease characteristics and with prognosis // Cancer, 1995. Vol. 76, N 9.-С.1564-1570
|
14.
| A phase I/II trial of Z-Dex (oral idarubicin and dexamethasone), an oral equivalent of VAD, as initial therapy at diagnosis or progression in multiple myeloma // Brit. J. Haematol., 1996. Vol. 93, N 4.-С.931-934
|
15.
| The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia // Blood, 1995. Vol. 86, N 6.-С.2091-2097
|
16.
| HyperCVAD for VAD-resistant multiple meyloma // Amer. J. Hematol., 1996. Vol. 52, N 2.-С.77-81
|
17.
| Solitary phalanx plasmacytoma relapse with disseminated extramedullary plasmacytomas and myeloma after short duration of remission // Anticancer Res., 1996. Vol. 16, N 2.-С.959-962
|
18.
| Multiple myeloma presenting as plasmacytoma of the base of the skull // Amer. J. Hematol., 1996. Vol. 52, N 1.-С.60-61
|
19.
| HyperCVAD for VAD-resistant multiple meyloma // Amer. J. Hematol., 1996. Vol. 52, N 2.-С.77-81
|
20.
| Multiple myeloma presenting as plasmacytoma of the base of the skull // Amer. J. Hematol., 1996. Vol. 52, N 1.-С.60-61
|
&uf('+1W2226#',v2226), ?>
|
|